A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures
Clinical trial NCT00233012 · COMPLETED
Trial details
- NCT number
- NCT00233012
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.